Discovery of a ligand that compensates for decreased
endogenous agonist potency of melanocortin - 4 receptor polymorphisms identified in obese humans.
Axelrod et al. «Cannabinoid Receptors and
Their Endogenous Agonist, Anandamide», Neurochemical Research, 23 (5): 575 - 581, 1998.
Not exact matches
Yachi, P.P., Lotz, C., Ampudia, J. & Gascoigne, N.R.J. T cell activation enhancement by
endogenous pMHC acts for both weak and strong
agonists but varies with differentiation state.